Publication of trials funded by the National Heart, Lung, and Blood Institute.
about
Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve MilestonesLikelihood of Null Effects of Large NHLBI Clinical Trials Has Increased over TimeSea change in open science and data sharing: leadership by industryTerminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for TerminationHow frequently do the results from completed US clinical trials enter the public domain?--A statistical analysis of the ClinicalTrials.gov database.Commentary on Vickers.Matching taxpayer funding to population health needs: not so simple.Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports.Opinion: Celebrating R and D expenditures badly misses the point.Publication Speed, Reporting Metrics, and Citation Impact of Cardiovascular Trials Supported by the National Heart, Lung, and Blood InstituteImpact of National Heart, Lung, and Blood Institute-Supported Cardiovascular Epidemiology Research, 1998 to 2012.Assessing value in biomedical research: the PQRST of appraisal and rewardEffect Sizes and Primary Outcomes in Large-Budget, Cardiovascular-Related Behavioral Randomized Controlled Trials Funded by NIH Since 1980.Biases in grant proposal success rates, funding rates and award sizes affect the geographical distribution of funding for biomedical research.Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusionSystematic review protocol assessing the processes for linking clinical trial registries and their published results.Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter?Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions.Efficient design of clinical trials and epidemiological research: is it possible?Impact of study outcome on submission and acceptance metrics for peer reviewed medical journals: six year retrospective review of all completed GlaxoSmithKline human drug research studies.The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses.Tracking Australian health and medical research expenditure with a PubMed bibliometric method.Positive Airway Pressure Therapies and Hospitalization in Chronic Obstructive Pulmonary Disease.The Positive and Negative about Positive Airway Pressure Therapy.Your American Journal of Ophthalmology: The Next ChapterAchieving Milestones as a Prerequisite for Proceeding With a Clinical Trial.From Nonclinical Research to Clinical Trials and Patient-registries: Challenges and Opportunities in Biomedical Research.Randomized controlled trials of rheumatoid arthritis registered at ClinicalTrials.gov: what gets published and when.Do trials reduce uncertainty? Assessing impact through cumulative meta-analysis of neonatal RCTs.
P2860
Q28076153-CD4D3F8B-318D-4854-9D4F-2BD287F96E43Q28644044-B236791B-53BD-455E-B402-1BBE46478CE0Q28656418-B73CC462-9171-47BD-9F00-E4B1A2719ABFQ30958675-40F31995-8A89-4563-AEFA-A845F3D0D539Q33903992-74C00553-39EA-4565-93DC-6D54BB571503Q34512503-E2638C1D-710E-4C69-BC5A-1047C059B949Q35592252-54B2D05D-69B8-4EF6-A3B6-449697382A95Q35716074-E2066C6B-86F2-4B97-9941-2CCCD022B64FQ35946320-166FF854-CB4E-4E4A-89A1-F7B97C17490BQ36141715-0C5BF1DE-F6D4-420D-88AA-7174861D5650Q36346547-B6CA36DB-AFEE-4B4F-8CF2-DEF537AEF730Q36395292-B1015F38-38A7-4AD2-A819-8E7D81969AA3Q36552536-2B1E734B-68FA-4820-B00B-21B946233444Q36794169-F3F9311C-147B-4295-A230-F3E1A6385641Q37216280-7213E0CB-E331-44C7-890F-B343D5885861Q37356008-A0992785-A65B-4544-8955-C9D438749A5FQ37516789-B9712747-6862-4A38-BD1D-0EAAC3907849Q37710165-0B4E7783-4D52-4089-ADA5-B28FF5D6275FQ38817527-A5035113-86FA-434E-8564-5E0D50BCE20EQ38825860-D2023726-AFF5-42C4-8B5A-B3D0E7705D05Q38952676-AF3C45B2-92F2-48AC-BCD7-1253319E928DQ39014986-6A719134-453D-4B11-98ED-CC9927812D21Q39019476-400DFFA6-49AD-42E0-A7BE-0EED7AE82FE9Q41115699-BC591C0D-82E7-4DA4-BAAA-5BF832F6184FQ41609331-977D0B3C-D3E6-4BB9-AF19-CCE30081547DQ47193341-E7B3377B-F4E6-4948-8F1E-73462D54CBBBQ47757313-758EFC1C-0FF0-4361-95F6-4BE67549A233Q48226590-57580967-5004-44EE-83A5-19863BE96DD8Q50208093-E1927A76-9371-4DCB-89C0-92BBF054500E
P2860
Publication of trials funded by the National Heart, Lung, and Blood Institute.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Publication of trials funded by the National Heart, Lung, and Blood Institute.
@en
Publication of trials funded by the National Heart, Lung, and Blood Institute.
@nl
type
label
Publication of trials funded by the National Heart, Lung, and Blood Institute.
@en
Publication of trials funded by the National Heart, Lung, and Blood Institute.
@nl
prefLabel
Publication of trials funded by the National Heart, Lung, and Blood Institute.
@en
Publication of trials funded by the National Heart, Lung, and Blood Institute.
@nl
P2093
P2860
P356
P1476
Publication of trials funded by the National Heart, Lung, and Blood Institute.
@en
P2093
Alice Mascette
David Gordon
Melissa Antman
Michael S Lauer
Peter G Kaufmann
Wendy Taddei-Peters
P2860
P304
P356
10.1056/NEJMSA1300237
P407
P577
2013-11-01T00:00:00Z